Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40.

Saved in:
Bibliographic Details
Title: Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40.
Authors: Wisch JK; Department of Neurology Washington University in Saint Louis St. Louis Missouri USA., Gordon BA; Department of Radiology Washington University in Saint Louis St. Louis Missouri USA.; Hope Center Washington University in Saint Louis St. Louis Missouri USA.; Knight Alzheimer Disease Research Center Washington University School of Medicine St Louis Missouri USA., Boerwinkle AH; Department of Neurology Washington University in Saint Louis St. Louis Missouri USA., Luckett PH; Department of Neurology Washington University in Saint Louis St. Louis Missouri USA., Bollinger JG; Department of Neurology Washington University in Saint Louis St. Louis Missouri USA.; The Tracy Family SILQ Center for Neurodegenerative Biology St. Louis Missouri USA., Ovod V; Department of Neurology Washington University in Saint Louis St. Louis Missouri USA.; The Tracy Family SILQ Center for Neurodegenerative Biology St. Louis Missouri USA., Li Y; Department of Radiology Washington University in Saint Louis St. Louis Missouri USA., Henson RL; Department of Neurology Washington University in Saint Louis St. Louis Missouri USA., West T; C2N Diagnostics St. Louis Missouri USA., Meyer MR; C2N Diagnostics St. Louis Missouri USA., Kirmess KM; C2N Diagnostics St. Louis Missouri USA., Benzinger TLS; Department of Radiology Washington University in Saint Louis St. Louis Missouri USA.; Knight Alzheimer Disease Research Center Washington University School of Medicine St Louis Missouri USA., Fagan AM; Department of Neurology Washington University in Saint Louis St. Louis Missouri USA.; Knight Alzheimer Disease Research Center Washington University School of Medicine St Louis Missouri USA., Morris JC; Department of Neurology Washington University in Saint Louis St. Louis Missouri USA.; Knight Alzheimer Disease Research Center Washington University School of Medicine St Louis Missouri USA., Bateman RJ; Department of Neurology Washington University in Saint Louis St. Louis Missouri USA.; The Tracy Family SILQ Center for Neurodegenerative Biology St. Louis Missouri USA., Ances BM; Department of Neurology Washington University in Saint Louis St. Louis Missouri USA.; Department of Radiology Washington University in Saint Louis St. Louis Missouri USA.; Hope Center Washington University in Saint Louis St. Louis Missouri USA.; Knight Alzheimer Disease Research Center Washington University School of Medicine St Louis Missouri USA., Schindler SE; Department of Neurology Washington University in Saint Louis St. Louis Missouri USA.; Knight Alzheimer Disease Research Center Washington University School of Medicine St Louis Missouri USA.
Source: Alzheimer's & dementia (Amsterdam, Netherlands) [Alzheimers Dement (Amst)] 2023 Mar 02; Vol. 15 (1), pp. e12405. Date of Electronic Publication: 2023 Mar 02 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Wiley on behalf of the Alzheimer's Association Country of Publication: United States NLM ID: 101654604 Publication Model: eCollection Cited Medium: Print ISSN: 2352-8729 (Print) Linking ISSN: 23528729 NLM ISO Abbreviation: Alzheimers Dement (Amst) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2352-8729
DOI:10.1002/dad2.12405